SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Deals
Despite Skepticism, Biogen Stock Explodes After Merck & Co. and Allergan Takeover Speculation
August 2, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
A Look at Four Biotech Giants’ Q2 Earnings
July 29, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Deals
Speculation Heats Up on Biogen as an Acquisition Target or Starting a Buying Spree
July 25, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Business
As Biogen Boss Moves to the Bay Area, California Biotechs Pay Attention
July 22, 2016
 · 
2 min read
How Biogen Makes Most of Its Cash
Business
Biogen CEO Steps Down Amid Stellar Q2 Financials, Hunt for New Leader Begins
July 21, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines
July 14, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Drug Development
With Little Fanfare, Biogen Sneaks Lupus Drug Into a Phase I Trial
July 14, 2016
 · 
2 min read
Business
Former Biogen Exec to Head Decibel Therapeutics, Plans to Fill 20 Jobs This Year, 40 to 60 in 2017
July 13, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Beach
4 High-Quality Biotechs Trading Like Risky Startups
July 11, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Deutsche Bank 37th Annual Healthcare Conference
May 3, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) Increases Revenue 7% to $1.3 Billion in the First Quarter
May 1, 2012
 · 
1 min read
Drug Development
New Tysabri Data Presented at 64th Annual American Academy of Neurology Meeting Highlight Biogen Idec, Inc. (Massachusetts) & Biogen Idec, Inc. (Massachusetts) Commitment to Improving Outcomes in Multiple Sclerosis
April 27, 2012
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Says Phase III Data Highlight Safety Profile For BG-12 MS Drug
April 24, 2012
 · 
9 min read
Genetown
New Data Presented at 64th American Academy of Neurology Annual Meeting Highlights Biogen Idec, Inc. (Massachusetts)'s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
April 23, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report First Quarter 2012 Financial Results on May 1, 2012
April 10, 2012
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Seeks $1 Billion Payoff for Solving Lou Gehrig’s Disease Puzzle
April 5, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) CEO Scangos Pay Reached $11.3 Million in 2011
March 27, 2012
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) Teams With MAKScientific for Up to $34 Million to Develop MS Drug
March 15, 2012
 · 
1 min read
Business
How Biogen Idec, Inc. (Massachusetts) Overhauled R&D Under Doug Williams
March 7, 2012
 · 
1 min read
Load More